BUND FINANCE

BUND FINANCE › Stocks › DHR

Danaher Corporation (DHR)

NYSE · Stock price, chart and technical analysis

US$228.41+2.64 (+1.17%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$225.77
OpenUS$227.00
Day rangeUS$225.44 – US$230.00
52-week rangeUS$160.93 – US$242.80
Market capUS$160.69B
Volume2.92M
50-day averageUS$223.36
200-day averageUS$201.06
Beta0.80
Last dividend per shareUS$1.52

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$29.5BUS$26.6BUS$23.9BUS$23.9BUS$24.6B
Net incomeUS$6.4BUS$7.2BUS$4.8BUS$3.9BUS$3.6B
EPS (diluted)8.619.646.385.295.05
Gross margin61.0%60.8%58.7%59.5%60.9%
Operating margin25.4%28.3%21.8%20.4%19.1%
Net margin21.8%27.1%19.9%16.3%14.7%
Free cash flowUS$7.1BUS$7.4BUS$5.8BUS$5.3BUS$5.3B
Total debtUS$23.3BUS$20.6BUS$19.5BUS$17.1BUS$18.4B
CashUS$2.6BUS$6.0BUS$5.9BUS$2.1BUS$4.6B

Compound annual growth: revenue -4.4% · net income -13.4% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E37.4x36.3x27.1x
EV / EBITDA25.6x23.5x16.5x
Operating margin20.4%—3.6%
Net margin16.9%—-0.0%
Debt / equity0.74—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Danaher Corporation

SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
CEOJulie Sawyer Montgomery
Employees59,000
IPO date1978-12-29

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongs…

www.danaher.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice